Inactive Instrument

Press Releases AroCell AB (publ) Nasdaq Stockholm

Equities

SE0003883990

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

AroCell - New patent approved on the US market	Apr. 19	AQ
New patent approved on the US market	Apr. 18	AQ
AroCell Attends Three Prestigious Events: AACR, EAU Congress and COG Nordics	Apr. 16	PU
AroCell publishes the Annual Report for 2023	Apr. 15	AQ
AroCell publishes the Annual Report for 2023	Apr. 12	AQ
The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024	Mar. 12	AQ
New Study: UBC Rapid can reduce the number of cystoscopies necessary in bladder cancer patients, enabling cost-effective follow-up	Mar. 12	AQ
Two Accepted Abstracts at AACR 2024 Explore Clinical Applications of TK1 Biomarker	Mar. 11	AQ
AroCell : Presentation at LabRoots 2024	Mar. 04	PU
AroCell Q4 - Nearing positive operating cash flow	Feb. 23	AQ
AroCell AB (publ) Interim Report January 1st to December 31st, 2023	Feb. 22	AQ
Ellen Dittberner, AroCell's CFO, will be taking parental leave, and Lars Jakobsson will step in as the interim CFO.	Feb. 01	AQ
AroCell has obtained regulatory approval for TUBEX TF in Ethiopia	Jan. 26	AQ
AroCell has obtained regulatory approval for TUBEX® TF in Ethiopia	Jan. 25	AQ
AroCell - Serum TK1 protein levels can predict survival of prostate cancer patients	Jan. 16	AQ
Serum TK1 protein levels can predict survival of prostate cancer patients	Jan. 15	AQ
AroCell nomination committee for the AGM 2024	Nov. 16	AQ
AroCell Q3 - Developing well, but looking over long-term forecasts	Nov. 06	AQ
AroCell AB (publ) Interim Report January 1st to September 30th, 2023	Nov. 02	AQ
New Study Highlights the Clinical Significance of TK1 SA for Early Detection of Ovarian Cancer	23-09-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AroCell AB (publ) Nasdaq Stockholm

Equities

SE0003883990

Press Releases

Filters